ArticleBMC immunology2024

Systemic treatment options for non-small cell lung cancer after failure of previous immune checkpoint inhibitors: a bayesian network meta-analysis based on randomized controlled trials.

Kang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.